Tag: Lung Cancer Medical Institute (ALCMI)
Disrupting the Paradigm: Partnering With Oncogene-Focused Patient Groups to Propel Research
By Amy C. Moore, PhD, and Upal Basu Roy, PhD, MPH
Posted: April 16, 2020
Genomic alterations drive more than 60% of adenocarcinoma cases of NSCLC.1...
